Changjiang Pharmaceutical Group (300391.SZ) announced that they have received a supervision letter jointly submitted by independent directors Mr. Deng Yuanjun, Ms. Lan Xia, and Mr. Wu Kangbing regarding the promotion of self-examination and correction and relevant work of Changjiang Pharmaceutical.
长药控股(300391.SZ)：收到独立董事督促函
Changjiang Pharmaceutical Group (300391.SZ): Received a letter from the independent director urging action.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.